FREE SHIPPING ON ORDERS OVER $150

first generic glp 1 Diabetes patients now have access to GLP-1 medication: ‘More accessible and affordable’ FDA Approves First Generic Daily

$25.37

Quantity
- +
Description

As more people use GLP-1 medications for weight loss or diabetes, some are noticing new and unexplained dental problems

first generic glp 1 Diabetes patients now have access to GLP-1 medication: More accessible and affordable FDA Approves First Generic Daily

10.1038/s41598-017-18259-0 47

first generic glp 1 Diabetes patients now have access to GLP-1 medication: More accessible and affordable FDA Approves First Generic Daily

Important safety considerations include a boxed warning for thyroid C-cell tumors, contraindications in patients with personal/family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2, and risks of pancreatitis, gallbladder disease, hypoglycemia (when used with insulin or insulin secretagogues), and acute kidney injury

first generic glp 1 Diabetes patients now have access to GLP-1 medication: More accessible and affordable FDA Approves First Generic Daily

The study analyzed data from over 1.6 million patients, comparing those treated with GLP-1 receptor agonists against those treated with insulin or metformin

first generic glp 1 Diabetes patients now have access to GLP-1 medication: More accessible and affordable FDA Approves First Generic Daily

You may also like

recommand products